AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Apimeds Pharmaceuticals US, Inc

$2.1 -$14.59 (-87.40%)
AMEX · 11 Sep 2026 19:56 UTC
Previous Close
$2.17
Day Range
$2.1$2.21
Year Range
$2.1$59.7
Market Cap
3.18M
AVG Volume
94.86K
Trailing/Forward PE
-0.04/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
New York Stock Exchange ArcaUS
Net Income (USD)
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-20.17M
26 Q1-35.06M
25 Q4-1.16M
25 Q3-1.78M
25 Q2-2.66M
25 Q1-402.4K
24 Q4-311.63K
24 Q3-332.52K
24 Q2-449.36K
24 Q1-296.47K
Operating Income (USD)
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-6.28M
26 Q1-4.07M
25 Q4-7.04M
25 Q3-1.84M
25 Q2-2.66M
25 Q1-364.37K
24 Q4-275.61K
24 Q3-300K
24 Q2-427.76K
24 Q1-271.73K
EBITDA (USD)
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-16.93M
26 Q1-34.18M
25 Q4-935.68K
25 Q3-1.77M
25 Q2-2.64M
25 Q1-364.37K
24 Q4-275.58K
24 Q3-299.88K
24 Q2-427.24K
24 Q1-269.56K
Cash Flows (USD)
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-6.18M
26 Q1-2.15M
25 Q4-3.84M
25 Q3-1.75M
25 Q2-3.37M
25 Q1-20.31K
24 Q4-99.62K
24 Q3-186.75K
24 Q2-184.06K
24 Q1-263.1K
EPS (USD)
-30-20-10024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-11.77
26 Q1-22.6
25 Q4-0.92
25 Q3-14
25 Q2-26
25 Q1-3.48
24 Q4-2.46
24 Q3-2.62
24 Q2-3.54
24 Q1-2.34
Expenses (USD)
05M10M15MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q26.28M
26 Q112.2M
25 Q47.06M
25 Q31.87M
25 Q22.68M
25 Q1364.37K
24 Q4275.61K
24 Q3300K
24 Q2427.76K
24 Q1271.73K
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2278.37K
26 Q12.48M
25 Q43.64M
25 Q36.99M
25 Q28.74M
25 Q1250.34K
24 Q43.46K
24 Q326.57K
24 Q263.33K
24 Q1147.38K
Debt ratios
-1012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.27
26 Q1-0.18
25 Q4-0.72
25 Q31.28
25 Q22.3
25 Q1-0.46
24 Q4-0.47
24 Q3-0.35
24 Q2-0.25
24 Q1-0.15
Return on Capital
-50%0%50%100%150%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Return on Capital by quarter
PeriodReturn on Capital
26 Q2-18.95%
26 Q1-27.71%
25 Q4-0.75%
25 Q3-21.83%
25 Q2-27.34%
25 Q122.86%
24 Q422.95%
24 Q331.78%
24 Q262.94%
24 Q1112.04%
Shares Outstanding
0500K1M1.5M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.63M
26 Q11.55M
25 Q41.09M
25 Q3125.76K
25 Q2103.69K
25 Q1115.72K
24 Q4115.27K
24 Q3115.27K
24 Q2115.27K
24 Q1115.27K
Book Value Per Share (USD)
-5005010015024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q265.19
26 Q181.55
25 Q4140.92
25 Q364.89
25 Q293.91
25 Q1-15.21
24 Q4-11.78
24 Q3-9.08
24 Q2-6.19
24 Q1-2.3
Total Assets (USD)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
APUS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2127.62M
26 Q1141.22M
25 Q4164.18M
25 Q39.25M
25 Q210.55M
25 Q1259.9K
24 Q413.06K
24 Q336.91K
24 Q273.66K
24 Q1157.72K
Employee Count
0246820242025
APUS Employee Count by quarter
PeriodEmployee Count
20257
20242
Free Cash Flow Yield
-500%-400%-300%-200%-100%0%med -175.75%Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
APUS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-403.97%
Sep 26-352.22%
Aug 26-220.25%
Aug 26-176.11%
Aug 26-187.33%
Aug 26-169.38%
Jul 26-139.12%
Jul 26-126.81%
Jul 26-108.56%
Jul 26-99.51%
Jul 26-79.61%
Jun 26-79.61%
Jun 26-65.73%
Jun 26-55.97%
Jun 26-56.42%
May 26-50.81%
May 26-55.03%
May 26-54.67%
May 26-54.67%
May 26-221.76%
Apr 26-221.76%
Apr 26-221.76%
Apr 26-221.76%
Apr 26-221.76%
Mar 26-218.28%
Mar 26-202.39%
Mar 26-257.36%
Mar 26-313.47%
Feb 26-306.56%
Feb 26-299.94%
Feb 26-338.96%
Feb 26-257.36%
Jan 26-225.36%
Jan 26-191.25%
Jan 26-243.81%
Jan 26-251.15%
Jan 26-249.65%
Dec 25-234.22%
Dec 25-274.29%
Dec 25-194.82%
Dec 25-194.82%
Nov 25-143.76%
Nov 25-182.86%
Nov 25-129.88%
Nov 25-159.2%
Oct 25-162.11%
Oct 25-179.3%
Oct 25-192.94%
Oct 25-188.84%
Oct 25-198.33%
Sep 25-183.94%
Sep 25-175.75%
Sep 25-170.68%
Sep 25-185.87%
Aug 25-194%
Aug 25-161.37%
Aug 25-26.51%
Aug 25-26.67%
Aug 25-24.37%
Jul 25-19.1%
Jul 25-23.96%
Jul 25-23.83%
Jul 25-23.83%
Jun 25-23.83%
Jun 25-26.02%
Jun 25-23.17%
Jun 25-21.97%
May 25-24.23%
May 25-35.16%
May 25-37.43%
May 25-28.93%
Price to Book
00.20.40.6med 0.21Oct 25Dec 25Jan 26Mar 26May 26Jul 26Sep 26
APUS Price to Book by quarter
PeriodPrice to Book
Sep 260.03
Sep 260.04
Aug 260.06
Aug 260.07
Aug 260.07
Aug 260.05
Jul 260.06
Jul 260.07
Jul 260.08
Jul 260.09
Jul 260.11
Jun 260.11
Jun 260.13
Jun 260.16
Jun 260.16
May 260.17
May 260.11
May 260.11
May 260.11
May 260.29
Apr 260.29
Apr 260.29
Apr 260.29
Apr 260.29
Mar 260.29
Mar 260.32
Mar 260.25
Mar 260.2
Feb 260.21
Feb 260.21
Feb 260.19
Feb 260.25
Jan 260.29
Jan 260.34
Jan 260.26
Jan 260.26
Jan 260.26
Dec 250.27
Dec 250.23
Dec 250.33
Dec 250.33
Nov 250.45
Nov 250.35
Nov 250.49
Nov 250.24
Oct 250.23
Oct 250.21
Oct 250.2
Oct 250.2
Oct 250.19
Sep 250.21
Sep 250.22
Sep 250.22
Sep 250.2
Aug 250.19
Aug 250.23
Apimeds Pharmaceuticals US, Inc
APUS
Stockpicker

Video analysis: APUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: APUS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.